Pilot Study Differential Dissectorâ„¢ for Blunt Dissection

Sponsor
University of North Carolina, Chapel Hill (Other)
Overall Status
Withdrawn
CT.gov ID
NCT02382952
Collaborator
(none)
0
2
16

Study Details

Study Description

Brief Summary

The primary purpose of this study is to evaluate the quality of blunt dissection during abdominal and pelvic surgery involving dissection of adhesions, separation of blood vessels and neurovascular structures while preserving the integrity of these structures.

Condition or Disease Intervention/Treatment Phase
  • Device: Differential Dissector
  • Other: Standard Dissection Method
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Official Title:
Pilot Study Differential Dissectorâ„¢ for Blunt Dissection
Study Start Date :
Mar 1, 2015
Anticipated Primary Completion Date :
Jul 1, 2016
Anticipated Study Completion Date :
Jul 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Differential Dissector

For patients in the study device group, blunt dissection will be performed with the Differential Dissector whenever the surgeon believes its use is appropriate.

Device: Differential Dissector

Active Comparator: Standard Dissection Method

For patients in the control group, blunt dissection will be performed by standard method.

Other: Standard Dissection Method

Outcome Measures

Primary Outcome Measures

  1. Operative Blood Loss [From start of surgery to wound closure]

  2. Post-operative Blood Loss [After surgical closure and drain insertion through drain removal]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age greater than 18

  • Patient will be undergoing open abdominal surgery

  • Patient willing and able to provide his/her own consent

Exclusion Criteria:
  • Current alcohol or other substance abuse

  • Current incarceration

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of North Carolina, Chapel Hill

Investigators

  • Principal Investigator: Mark Koruda, MD, University of North Carolina, Chapel Hill

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of North Carolina, Chapel Hill
ClinicalTrials.gov Identifier:
NCT02382952
Other Study ID Numbers:
  • 14-2888
First Posted:
Mar 9, 2015
Last Update Posted:
Aug 5, 2016
Last Verified:
Jul 1, 2016
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by University of North Carolina, Chapel Hill
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 5, 2016